Cargando…

C-reactive protein: A promising biomarker for poor prognosis in COVID-19 infection

BACKGROUND: The novel coronavirus disease 2019 (COVID-19) first broke out in Wuhan, China, spread over 227 countries and caused approximately 0.3 million death worldwide. Several biomolecules have been explored for possible biomarkers for prognosis outcome. Although increased C reactive protein (CRP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sahu, Bikash R., Kampa, Raj Kishor, Padhi, Archana, Panda, Aditya K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274122/ https://www.ncbi.nlm.nih.gov/pubmed/32511972 http://dx.doi.org/10.1016/j.cca.2020.06.013

Ejemplares similares

C-Reactive Protein (CRP): A poor prognostic biomarker in COVID-19
por: Bouayed, Mohamed Zakaria, et al.
Publicado: (2022)

CCR5 Δ32 minorallele is associated with susceptibility to SARS-CoV-2 infection and death: An epidemiological investigation
por: Panda, Aditya K., et al.
Publicado: (2020)

PFKFB4 as a promising biomarker to predict a poor prognosis in patients with gastric cancer
por: Wang, Fang, et al.
Publicado: (2021)

Elevated serum C-reactive protein level predicts a poor prognosis for recurrent gastric cancer
por: Kong, Fanming, et al.
Publicado: (2016)

ULK1: A Promising Biomarker in Predicting Poor Prognosis and Therapeutic Response in Human Nasopharygeal Carcinoma
por: Yun, Miao, et al.
Publicado: (2015)

C-Reactive Protein, a Promising Approach for Acetaminophen Hepatotoxicity
por: Garcia-Ruiz, Carmen, et al.
Publicado: (2021)

High Expression of CEMIP Correlates Poor Prognosis and the Tumur Microenvironment in Breast Cancer as a Promisingly Prognostic Biomarker
por: Dong, Xingxing, et al.
Publicado: (2021)

Upregulation of circulating cytokeratin 20, urokinase plasminogen activator and C-reactive protein is associated with poor prognosis in gastric cancer
por: TANG, ZHONGZHU, et al.
Publicado: (2015)

Postoperative C-reactive protein-to-albumin ratio predicts poor prognosis in patients with bladder cancer undergoing radial cystectomy
por: Kuroda, Kenji, et al.
Publicado: (2021)

Rap2c as a Novel Biomarker for Predicting Poor Prognosis in Glioma
por: Wang, Xiucun, et al.
Publicado: (2020)

C-reactive protein to lymphocyte count ratio is a promising novel marker in hepatitis C infection: the clear hep-c study
por: Demirkol, Muhammed Emin, et al.
Publicado: (2022)

Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer
por: Larsson, Anna, et al.
Publicado: (2012)

Biomarker for Cancer: A great Promise for Future
por: Karley, Dugeshwar, et al.
Publicado: (2011)

C-Reactive Protein and Prognosis in Diabetes: Getting to the Heart of the Matter
por: Sattar, Naveed, et al.
Publicado: (2009)

Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study
por: Allin, Kristine H, et al.
Publicado: (2011)

Apoptosis-associated biomarkers in tuberculosis: promising for diagnosis and prognosis prediction
por: Shu, Chin-Chung, et al.
Publicado: (2013)

Urinary Tract Infection due to Paenibacillus alvei in a Chronic Kidney Disease: A Rare Case Report
por: Padhi, Sanghamitra, et al.
Publicado: (2013)

Death from rabies: The reason being poor compliance to vaccination or it's failure
por: Kumar, Shyam Kishor, et al.
Publicado: (2020)

Prognosis of COVID-19: Red Cell Distribution Width, Platelet Distribution Width, and C-Reactive Protein
por: Bommenahalli Gowda, Shivakumar, et al.
Publicado: (2021)

Membranous Nephropathy with Collapse: Poor Prognosis
por: Bharati, Joyita, et al.
Publicado: (2020)

MDFI is a novel biomarker for poor prognosis in LUAD
por: Chen, Pengyu, et al.
Publicado: (2022)

Raised C-reactive protein on ICU discharge is not associated with subsequent poor outcome
por: Reynolds, TE, et al.
Publicado: (2009)

The Elevated Pre-Treatment C-Reactive Protein Predicts Poor Prognosis in Patients with Locally Advanced Rectal Cancer Treated with Neo-Adjuvant Radiochemotherapy
por: Partl, Richard, et al.
Publicado: (2020)

Predictor parameters for poor prognosis in patients with sudden sensorineural hearing loss: fibrinogen to albumin ratio vs C-reactive protein to albumin ratio
por: Cayir, Serkan, et al.
Publicado: (2020)

pTERT C250T mutation: A potential biomarker of poor prognosis in metastatic melanoma
por: Blanco-García, Leyla, et al.
Publicado: (2023)

Lower levels of vitamin D are associated with SARS-CoV-2 infection and mortality in the Indian population: An observational study
por: Padhi, Sunali, et al.
Publicado: (2020)

Baseline C-Reactive Protein Levels and Life Prognosis in Parkinson Disease
por: Sawada, Hideyuki, et al.
Publicado: (2015)

Baseline C-reactive protein levels and prognosis in patients with infective endocarditis: A prospective cohort study
por: Mohanan, Sandeep, et al.
Publicado: (2018)

Inhibiting C-Reactive Protein for the Treatment of Cardiovascular Disease: Promising Evidence from Rodent Models
por: Szalai, Alexander J., et al.
Publicado: (2014)

Hsa-miR-665 Is a Promising Biomarker in Cancer Prognosis
por: Guan, Xuefeng, et al.
Publicado: (2023)

C-Reactive Protein as a Biomarker for Major Depressive Disorder?
por: Orsolini, Laura, et al.
Publicado: (2022)

C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review
por: Shrotriya, Shiva, et al.
Publicado: (2015)

Poor Prognosis of Diffuse Large B-Cell Lymphoma with Hepatitis C Infection
por: Tsai, Yu-Fen, et al.
Publicado: (2021)

ACE deletion allele is associated with susceptibility to SARS-CoV-2 infection and mortality rate: An epidemiological study in the Asian population
por: Pati, Abhijit, et al.
Publicado: (2020)

C-Reactive Protein-to-Albumin Ratio (CAR) and C-Reactive Protein-to-Lymphocyte Ratio (CLR) are Valuable Inflammatory Biomarker Combination for the Accurate Prediction of Periprosthetic Joint Infection
por: Shi, Weipeng, et al.
Publicado: (2023)

Discovery of dachshund 2 protein as a novel biomarker of poor prognosis in epithelial ovarian cancer
por: Nodin, Björn, et al.
Publicado: (2012)

Predictive implications of albumin and C-reactive protein for progression to pneumonia and poor prognosis in Stenotrophomonas maltophilia bacteremia following allogeneic hematopoietic stem cell transplantation
por: Harada, Kaito, et al.
Publicado: (2017)

High levels of C‐reactive protein‐to‐albumin ratio (CAR) are associated with a poor prognosis in patients with severe fever with thrombocytopenia syndrome in early stage
por: Liu, Zishuai, et al.
Publicado: (2022)

Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis
por: Ielapi, Nicola, et al.
Publicado: (2020)

Overexpression of C-reactive Protein as a Poor Prognostic Marker of Resectable Hepatocellular Carcinomas
por: Shin, Jin Ho, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vqqnnd5d3k00jolmbjtee207r0